BYDUREON is a Kit in the Human Prescription Drug category. It is labeled and distributed by Astrazeneca Pharmaceuticals Lp. The primary component is .
Product ID | 0310-6520_160ba882-6c8c-4495-8c99-37cf8d20ac77 |
NDC | 0310-6520 |
Product Type | Human Prescription Drug |
Proprietary Name | BYDUREON |
Generic Name | Exenatide |
Dosage Form | Kit |
Marketing Start Date | 2015-02-01 |
Marketing Category | NDA / NDA |
Application Number | NDA022200 |
Labeler Name | AstraZeneca Pharmaceuticals LP |
Active Ingredient Strength | 0 |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2015-02-01 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA022200 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2015-02-01 |
Marketing End Date | 2020-11-30 |
SPL SET ID: | 71fe88be-b4e6-4c2d-9cc3-8b1864467776 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0310-6520 | BYDUREON | exenatide |
0310-6530 | BYDUREON | exenatide |
0310-6540 | BYDUREON BCise | exenatide |
0310-6512 | Byetta | exenatide |
0310-6524 | Byetta | exenatide |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
BYDUREON 85329947 4169150 Live/Registered |
AMYLIN PHARMACEUTICALS, LLC 2011-05-25 |
BYDUREON 77331009 not registered Dead/Abandoned |
Amylin Pharmaceuticals, Inc 2007-11-15 |